CryoLife, Inc. (NYSE:CRY) manufactures, processes, and distributes medical devices and implantable living tissues used in cardiac and vascular surgical procedures. From mid-April until early October, the stock has done well, rising over 60%. Since then however, the share price dropped 20% due to a disappointing Q3 earnings report and lowered full-year guidance, resulting at least partially from the negative impact of recent hurricanes. The share price further plummeted after the company announced a $225 million acquisition of JOTEC, German-based, privately-held developer of technologically differentiated endovascular stent grafts.
CRY data by YCharts
Hot Medical Stocks To Watch Right Now: Patriot National Bancorp Inc.(PNBK)
Advisors’ Opinion:
- [By Shane Hupp]
Patriot National Bancorp (NASDAQ: PNBK) and Community Bank, N.A. (NYSE:CBU) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability.
Hot Medical Stocks To Watch Right Now: Rada Electronics Industries Limited(RADA)
Advisors’ Opinion:
- [By Logan Wallace]
TESSCO Technologies (NASDAQ: TESS) and RADA Electronic Industries (NASDAQ:RADA) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings.
Hot Medical Stocks To Watch Right Now: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)
Advisors’ Opinion:
- [By Jim Crumly]
Semiconductor stocks rose on news of a deal with China to grant a reprieve to ZTE, with theiShares PHLX Semiconductor ETF (NASDAQ:SOXX) moving up 1.2%.Energy shares gained, too; the SPDR S&P Oil & Gas Exploration & Production ETF (NYSEMKT:XOP) closed up 1.3%.
- [By Joseph Griffin]
Essex Financial Services Inc. bought a new position in iShares PHLX Semiconductor ETF (NASDAQ:SOXX) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,765 shares of the exchange traded fund’s stock, valued at approximately $318,000.
Hot Medical Stocks To Watch Right Now: BioCryst Pharmaceuticals Inc.(BCRX)
Advisors’ Opinion:
- [By Ethan Ryder]
Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on BioCryst Pharmaceuticals (BCRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
